Modeka Chemicals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.68 M
- Company Age 44 Year, 2 Months
- Last Filing with ROC 31 Mar 2019
- Satisfied Charges ₹ 4.21 M
- Revenue Growth -2.34%
- Profit Growth 85.10%
- Ebitda 79.75%
- Net Worth -4.29%
- Total Assets 0.86%
About Modeka Chemicals
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24231MH1980PTC023514
-
Company No.
023514
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 Dec 1980
-
Date of AGM
20 Sep 2019
-
Date of Balance Sheet
31 Mar 2019
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Modeka Chemicals?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Anand Kagal
![]() |
Director | 20-Oct-2015 | Current |
Jyoti Kagal
![]() |
Director | 24-Feb-2016 | Current |
Financial Performance of Modeka Chemicals.
Modeka Chemicals Pvt Ltd, for the financial year ended 2016, experienced Minor drop in revenue, with a 2.34% decrease. The company also saw a substantial improvement in profitability, with a 85.1% increase in profit. The company's net worth dipped by a decrease of 4.29%.
![Graph illustrating revenue growth over time](/Images/financial/revenue-growth.webp)
![Graph showing profit and loss trends over time](/Images/financial/profit-loss.webp)
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Modeka Chemicals?
In 2017, Modeka Chemicals had a promoter holding of 26.43% and a public holding of 73.57%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
![Shareholding Indicator graph](/Images/tcc-login/Shareholding-Indiacator-1200.webp)
Charges (Loans)
₹0
₹4.21 M
Charges Breakdown by Lending Institutions
- Bank Of Baroda : 0.42 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
19 Jun 1995 | Bank Of Baroda | ₹0.80 M | Satisfied |
19 Jun 1995 | Bank Of Baroda | ₹1.12 M | Satisfied |
19 Jun 1995 | Bank Of Baroda | ₹0.80 M | Satisfied |
14 Sep 1993 | Bank Of Baroda | ₹0.25 M | Satisfied |
14 Sep 1993 | Bank Of Baroda | ₹0.10 M | Satisfied |
How Many Employees Work at Modeka Chemicals?
Unlock and access historical data on people associated with Modeka Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
![Graph showing employee growth trends](/Images/tcc-login/Employee-Graph.webp)
Deals i
![Graph showing company valuation over time](/Images/tcc-login/Valuation-Graph-small.webp)
Gain comprehensive insights into the Deals and Valuation data of Modeka Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Modeka Chemicals's trajectory.
Rating
![Graph displaying rating trends over time](/Images/tcc-login/Rating-Graph-small.webp)
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
![Alert Indicator](/Images/tcc-login/Alert-Indicator-small.webp)
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.